ArticleFrontiers in genetics2021
Predicting miRNA-Disease Associations Based on Heterogeneous Graph Attention Networks.
Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Hierarchical graph attention network for miRNA-disease association prediction.Molecular therapy : the journal of the American Society of Gene Therapy · 2022Article
- Quantum graph embedding of transcription factor-gene networks reveals key modules in periodontal bone inflammation: Comparative analysis of GAE and GAN.Journal of oral biology and craniofacial researchArticle
- Predictive modeling of stem cell suppression by inflammatory cytokine networks: A synthetic transcriptomic approach for periodontal tissue engineering.Journal of oral biology and craniofacial researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In recent years, more and more evidence has shown that microRNAs (miRNAs) play an important role in the regulation of post-transcriptional gene expression, and are closely related to human diseases. Many studies have also revealed that miRNAs can be served as promising biomarkers for the potential diagnosis and treatment of human diseases. The interactions between miRNA and human disease have rarely been demonstrated, and the underlying mechanism of miRNA is not clear. Therefore, computational approaches has attracted the attention of researchers, which can not only save time and money, but also improve the efficiency and accuracy of biological experiments. In this work, we proposed a Heterogeneous Graph Attention Networks (GAT) based method for miRNA-disease associations prediction, named HGATMDA. We constructed a heterogeneous graph for miRNAs and diseases, introduced weighted DeepWalk and GAT methods to extract features of miRNAs and diseases from the graph. Moreover, a fully-connected neural networks is used to predict correlation scores between miRNA-disease pairs. Experimental results under five-fold cross validation (five-fold CV) showed that HGATMDA achieved better prediction performance than other state-of-the-art methods. In addition, we performed three case studies on breast neoplasms, lung neoplasms and kidney neoplasms. The results showed that for the three diseases mentioned above, 50 out of top 50 candidates were confirmed by the validation datasets. Therefore, HGATMDA is suitable as an effective tool to identity potential diseases-related miRNAs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.